Standardization of a fragmented dermatophyte mycelial inoculum free of conidia for use in a broth microculture antimycotic susceptibility testing system is described. Ten clinical dermatophyte isolates were grown in submerged broth cultures at 35°C. The mycelia were harvested before conidia appeared and were fragmented to 10 to 50-,um segments with a Broeck ground-glass tissue grinder. The density of the fragmented mycelium preparation was found to be adjustable on the basis of its spectrophotometric density expressed as absorbance measured at 450 nm. The minimal absorbance density that produced a 100% inoculation efficiency was determined for each isolate, and from these data an absorbance density of 0.600 was selected for inoculation of microcultures used in antimycotic susceptibility testing. The 0.600-absorbance inoculum of each dermatophyte isolate was tested for its capacity to successfully inoculate antimycotic agentcontaining microcultures and generate minimal inhibitory concentrations of griseofulvin, clotrimazole, miconazole, and ketoconazole. The effect of the length of incubation on the minimal inhibitory concentrations was determined. It was concluded that the 0.600-absorbance density fragmented mycelial inoculum assured the rapid and uniform inoculation of the broth microculture antimycotic susceptibility system.
Standardization of a fragmented dermatophyte mycelial inoculum free of conidia for use in a broth microculture antimycotic susceptibility testing system is described. Ten clinical dermatophyte isolates were grown in submerged broth cultures at 35°C. The mycelia were harvested before conidia appeared and were fragmented to 10 to 50-,um segments with a Broeck ground-glass tissue grinder. The density of the fragmented mycelium preparation was found to be adjustable on the basis of its spectrophotometric density expressed as absorbance measured at 450 nm. The minimal absorbance density that produced a 100% inoculation efficiency was determined for each isolate, and from these data an absorbance density of 0.600 was selected for inoculation of microcultures used in antimycotic susceptibility testing. The 0.600-absorbance inoculum of each dermatophyte isolate was tested for its capacity to successfully inoculate antimycotic agentcontaining microcultures and generate minimal inhibitory concentrations of griseofulvin, clotrimazole, miconazole, and ketoconazole. The effect of the length of incubation on the minimal inhibitory concentrations was determined. It was concluded that the 0.600-absorbance density fragmented mycelial inoculum assured the rapid and uniform inoculation of the broth microculture antimycotic susceptibility system. Antimicrobial susceptibility testing of fungi is not as technologically advanced as the susceptibility testing of bacteria. This is particularly true for susceptibility testing of filamentous fungi such as the dermatophytes, where selection of the inoculum form, its preparation, and standardization present major obstacles.
Two forms of inoculum have been used with dermatophytic fungi. These are conidial suspensions (1, 3, 4) and whole-culture elements consisting of a mixture of mycelium and conidia (1, 6, 8, 10 Control cultures received 10 LI of sterile water or 10 p1 of 50% ethanol. The cultures were inoculated with 10 pd of fragmented mycelium adjusted to an absorbance of 0.600, sealed, and incubated as described above. Readings were made at 2, 4, and 6 days. The concentration of antimycotic agent that caused complete inhibition of growth after 4 days was defined as the minimal inhibitory concentration (MIC).
RESULTS
The first experiment was designed to microscopically characterize the fragmented mycelial preparation and determine whether exhaustive grinding appreciably changed the fragment size. Ten exponential-phase mycelial cultures were fragmented in Broeck grinders as described in Materials and Methods. The fragmented mycelial preparations were examined microscopically to determine the size and consistency of the fragments. A typical mycelial preparation, immediately after fragmentation to the point that there are no visible clumps within the grinding vessel, is depicted in Fig. 1 . The resulting mycelial fragments were found to range in size between 10 and 50 ym, with occasional branching. Additional grinding did not appreciably change the nature of the inoculum. Several of the fungi required more grinding to reach the visually clump-free condition. This is believed to result from the inherent difference between one grinder and another rather than a difference in the fungi.
The second experiment spectrophotometrically defined the quantity of fragmented mycelium needed to insure that fungal growth will be consistently initiated in 200-,ul ing, the meaning of the in vitro-derived MIC of a given antimycotic agent must be established by correlation with the outcome of therapy with that drug. At present, data of this type do not exist because of the past paucity of antimycotic agents and, more recently, because of the difficulties involved in performing amtimycotic susceptibility testing.
Our laboratory has set out to determine the usefulness of antimycotic susceptibility testing for predicting the outcome of antimycotic therapy in dermatophytic infections. The first step of our endeavor has been the development of an antimycotic susceptibility testing system that is not physically cumbersome with a large number of broth tubes or agar plates. This is necessary because a large number of isolates will be tested, many of them simultaneously, using an experimental design where replicate data are generated. Because of these and other considerations a micronutrient broth system was selected (4) .
In this paper we address the selection and preparation of the dermatophyte fungal inoculum for use in a broth microculture. This is important because the form and the availability of the inoculum will determine the ease with which antimycotic susceptibility testing can be performed and may affect the MIC (2, 10). We have selected the mycelial form because it is readily available, has less morphological variability than conidia, and is the formn that is found within the stratum corneum of an infected individual.
We have determined that the mycelial form of most dermatophytes will be free of conidia if grown submerged in shallow nutrient broth cultures at 32 to 35°C, which is the approximate temperature at the skin surface of humans (7) . At this temperature dermatophyte growth is accelerated above that which occurs at room temperature, and sufficient mycelial material is available for inoculum preparation in 2 to 6 days. In contrast to mycelium, conidia are not readily produced by all dermatophytes, may have variable morphology (microaleurospores versus macroaleurospores), and require a longer period of growth before appearing (5) .
The use of mycelium necessitates that it be fragmented so that it can be easily dispersed in equal amounts to all microcultures. Others have accomplished this by fragmentation in a ball mill using glass beads (10) . We have found that the use of a ground-glass Broeck grinder is more rapid and produces more uniform mycelial fragments, the density of which can be easily adjusted by dilution based upon a spectrophotometric determination of absorbance.
The minimal effective inoculum for microcultures was determined and found to occur at a density absorbance of 0.600 measured at 450 run ( Table 1) . Selection of inoculum quantity on the basis of density, however, does not take into account the probable variability of delivered viable fragments from one preparation to another. The effect on MIC determinations of using a variable quantity of viable units while keeping the fungal mass constant is not known. However, it has been suggested that changing the mass of inoculum may affect the MIC (2). Our technique assures that each microculture will receive approximately the same mass of mycelium.
That the fragmented mycelium inoculum lends itself to the antimycotic susceptibility testing of dernatophytes in microculture is demonstrated by the data summarized in Table 2 . These data were obtained in quadruplicate, which required the rapid inoculation of 1,920 separate microcultures. This was readily accomplished using an automatic pipette. We are currently using the fragmented mycelium and the broth microculture system in our laboratory to determine the relationship between the MIC and therapeutic efficacy for dermatophytes. Griseofulvin-resistant dermatophytes have been identified. Several of these are included in Table  2 (isolates 1, 4, and 8). The reproducibility of these results has been confirmed and will be described elsewhere.
The fragmented mycelium inoculum also lends itself to the antimycotic susceptibility testing of nondermatophyte filamentous fungi. We have used this inoculum form in microcultures to perform susceptibility tests on clinical isolates of Aspergillus, Curvularia, Alternaria, Cladosporium, and Rhizopus species.
